918 Functional heterogeneity of CD4+ tumor-infiltrating lymphocytes

• Marco Donia,
• Mads H Andersen,
• Martin Lauss,
• Göran Jönsson,
• Arianna Draghi,
• Katja Harbst,
• Inge Svane,
• Torben Lorentzen,
• Shawez Khan,
• Mario Presti,
• Christopher A Chamberlain,
• Agnete WP Jensen,
• Michael D Crowther,
• Anne-Christine K Rasmussen,
• Benedetta Albieri

Affiliations

Marco Donia

Center for Cancer Immune Therapy, Herlev, Denmark

Mads H Andersen

Aff1 grid.411900.d0000000406468325Center for Cancer Immune Therapy, Department of HaematologyCopenhagen University Hospital at Herlev Herlev Denmark

Martin Lauss

Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden

Göran Jönsson

5Division of Oncology and Pathology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Lund, Sweden

Arianna Draghi

National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Herlev Hospital, Herlev, Denmark

Katja Harbst

Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden

Inge Svane

2National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark

Torben Lorentzen

Department of Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark

Shawez Khan

3Center for Cancer Immune Therapy, Herlev, Denmark

Mario Presti

Center for Cancer Immune Therapy, Herlev, Denmark

Christopher A Chamberlain

Center for Cancer Immune Therapy, Herlev, Denmark

Agnete WP Jensen

1National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark

Michael D Crowther

1National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark

Anne-Christine K Rasmussen

2National Center for Cancer Immune Therapy(CCIT-DK), Herlev, Denmark

Benedetta Albieri

1National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark